The present invention is directed to new kahalalide antitumoral compounds, in particular to analogues of kahalalide F, useful as antitumoral, antiviral, antifungal agents and in the treatment of psoriasis.

 
Web www.patentalert.com

< Receptor modulated cancer protocols

> Compounds with sulphonamide group and pharmaceutical compositions containing these compounds

> Compounds for use in weight loss and appetite suppression in humans
~ 00506